WallStSmart
GRI

GRI Bio Inc.

NASDAQ: GRI · HEALTHCARE · BIOTECHNOLOGY

$2.23
-5.51% today

Updated 2026-04-29

Market cap
$3.41M
P/E ratio
P/S ratio
EPS (TTM)
$-121.80
Dividend yield
52W range
$2 – $80
Volume
0.1M

GRI Bio Inc. (GRI) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-67.1%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-1487.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-4.1%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-13.9%
2026-01-30
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-01-30$-116.61-298.5%$3.32$2.86-13.9%
2025-11-14$-35.84-15.3%$1.69$1.60-5.3%
2025-08-14$-36.68+0.0%$1.30$1.39+6.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-29.26$-116.61-298.5%
2025-09-30$-31.08$-35.84-15.3%$6.33M
2025-06-30$-36.68$-36.68+0.0%$22.54M
2025-03-31$-105.98$-162.40-53.2%
2024-12-31$-5.44$-7.34-35.0%$2.30M-57.4%
2024-09-30$-347.48$-318.92+8.2%
2024-06-30$-4.92
2024-03-31$-3.10
2023-12-31$-3.10$5.39M
2023-09-30$-0.52
2023-06-30$-4,316.37
2023-03-31$0.00$-5.33

Frequently asked questions

Has GRI Bio Inc. beaten earnings estimates?
GRI Bio Inc. has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -67.1% over the last 4 quarters.
How does GRI stock react to earnings?
GRI stock has moved an average of -4.1% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.